Please try another search
AroCell AB (publ), a vitro diagnostics company, develops and markets blood and urine sample test products for use in the treatment of breast, prostate, and bladder cancers. The company provides AroCell TK 210 ELISA, an immunoassay kit for the determination of human Thymidine Kinase 1 protein concentration in blood samples; and UBC Rapid for diagnosing and monitoring bladder cancer patients. It also offers TUBEX TF, an in vitro diagnostic test for the detection of acute typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Agneta Franksson | 60 | 2017 | Independent Director |
Staffan Eriksson | - | 2003 | Member of Advisory Board |
Charlotta Ljungqvist | 62 | 2021 | Independent Director |
Clas G. Runnberg | 71 | 2023 | Independent Director |
Max Pihlqvist | 36 | 2022 | Director |
Eva Nordström | 53 | 2020 | Independent Director |
Johan Haggblad | 65 | 2022 | Independent Chairman |
Agneta Tufvesson Alm | 59 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review